California-based BridgeBio has secured US FDA approval for its lead candidate drug, acoramidis (brand name Attruby) for ...

Amsterdam-based Cradle, an AI-powered platform revolutionising protein engineering, has secured $73 million in Series B funding to meet growing demand in research-intensive industries. Led by IVP with ...

The epidemiological landscape of HIV has transformed dramatically over the past several decades. Once a terminal diagnosis ...

Alector is kicking off a resource realignment effort that will include a workforce reduction of around 17%. The biotech ...

Truqap’s positive clinical data comes after it failed a late-stage study in metastatic triple-negative breast cancer. It ...